Please login to the form below

Not currently logged in
Email:
Password:

metreleptin

This page shows the latest metreleptin news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

Another orphan drug, Novelion’s Myalepta (metreleptin) also received a positive opinion, for the treatment of leptin deficiency, while Lundbeck and Otsuka’s Rxulti (brexpiprazole) was recommended for the treatment of

Latest news

  • R&D productivity takes off R&D productivity takes off

    For example, Amgen's Blincyto (blinatumomab) for a rare form of leukaemia has been priced at $178, 000 a year, while AZ's Myalept (metreleptin) for the ultra-rare metabolic disorder

  • Nexium windfall lifts AZ in third quarter Nexium windfall lifts AZ in third quarter

    Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals.

  • FDA approves AZ’s fish oil drug FDA approves AZ’s fish oil drug

    Epanova gets green light to reduce high levels of fat in the blood

  • AZ gets limited approval for metreleptin in US AZ gets limited approval for metreleptin in US

    AZ gets limited approval for metreleptin in US. First FDA-backed treatment for rare disease lipodystrophy. ... The company stressed that metreleptin is not approved to treat the complications of lipodystrophy, such as liver disease, or for

  • AstraZeneca buys BMS out of diabetes alliance AstraZeneca buys BMS out of diabetes alliance

    year. AZ now has full control of three Amylin-developed products, namely the GLP-1 agonists Byetta (exenatide), Bydureon (exenatide extended-release) and Symlin (pramlintide acetate), as well as metreleptin for

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics